home > News and Publications > Publications
Affordable Access to Insulin and Pharmacy Refill Legislation Head to Governor’s Desk; Flavored Tobacco/Nicotine Products Not Snuffed Out Yet
Posted on: 11/18/2019
PA-graphic-11_22 vape

The fall veto session wrapped up last week in Springfield. Several notable healthcare issues were on the table:

  • Senate Bill 2104 cleared the General Assembly with an important provision related to automated prescription refills. Patients will now have to opt in to receive automatic refills, rather than being enrolled without their knowledge. Additionally, electronic prescribing systems must allow physicians to cancel prescriptions electronically. These changes mean that patients will no longer be taking medications unnecessarily as a result of unsolicited auto-refills, and physicians will no longer be burdened by calls from pharmacists confused about refills for prescriptions that are no longer needed.

This proposal originated with a resolution submitted by a concerned ISMS member – another example of how ISMS helps Illinois physicians Be Heard! The resolution deadline for the 2020 Annual Meeting is January 7. Click here for more information about submitting your idea.

Both chambers voted unanimously in favor of the bill (House: 113-0; Senate 52-0). The bill will be sent to the governor for consideration.

  • Senate Bill 667 also cleared the General Assembly. This bill would cap out-of-pocket insulin costs for patients to $100 for a 30-day supply.* This ISMS-supported proposal passed 48-7 in the Senate and 100-13 (with 1 voting present) in the House.

This bill will be sent to the governor for consideration; he has pledged to sign it.

  • Legislation (Senate Bill 668; House Bill 3883) that would have banned the sale of any flavored tobacco product and nicotine product did not pass out of the House or Senate during the veto session; however, this bill will likely surface again in the 2020 Spring Legislative session. Stay tuned!

Questions? Please contact ISMS Vice President of Legislative Affairs Erin O'Brien at 312-580-6488.

*This legislation covers the approximate 20% of Illinois patients who are diabetic and covered by state-regulated insurance plans. Federally regulated plans, such as Medicare, Medicaid and ERISA plans sponsored by large employers, are unaffected.



View Full Site View Mobile Site